BAKER BROS. ADVISORS LP – CymaBay Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$7.59M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+18.64%
quarter
CymaBay Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 1.19M | $3.5 | 2.17M | |
Q2 2022 | share | 0.00% | 0 shares | -347K | $2.95 | 2.17M | |
Q1 2022 | share | 0.00% | 0 shares | -586K | $3.11 | 2.17M | |
Q4 2021 | share | 0.00% | 0 shares | -586K | $3.3 | 2.17M | |
Q3 2021 | share | 0.00% | 0 shares | -1.54M | $3.65 | 2.17M | |
Q2 2021 | share | 0.00% | 0 shares | -391K | $4.36 | 2.17M | |
Q1 2021 | share | Decrease | -24.98% | -722.81K shares | -6.75M | $4.54 | 2.17M |
Q4 2020 | share | Decrease | -11.05% | -359.26K shares | -6.94M | $5.74 | 2.89M |
Q3 2020 | share | Increase | +113.59% | 1.72M shares | 18.23M | $7.24 | 3.25M |
Q2 2020 | share | Increase | 0.00% | 1.52M shares | 5.31M | $3.49 | 1.52M |
Q4 2019 | share | Decrease | -100.00% | -5.70M shares | -29.22M | $1.96 | 0 |
Q3 2019 | share | 0.00% | 0 shares | -11.64M | $5.12 | 5.70M | |
Q2 2019 | share | 0.00% | 0 shares | -34.92M | $7.16 | 5.70M | |
Q1 2019 | share | Increase | +16.06% | 789.71K shares | 37.09M | $13.28 | 5.70M |
Q4 2018 | share | 0.00% | 0 shares | -15.78M | $7.87 | 4.91M | |
Q3 2018 | share | 0.00% | 0 shares | -11.50M | $11.08 | 4.91M | |
Q2 2018 | share | Increase | +25.53% | 1M shares | 15.10M | $13.42 | 4.91M |
Q1 2018 | share | Increase | +30.95% | 925.92K shares | 23.36M | $12.99 | 3.91M |
Q4 2017 | share | 0.00% | 0 shares | 3.41M | $9.2 | 2.99M | |
Q3 2017 | share | Increase | +131.60% | 1.7M shares | 16.67M | $8.06 | 2.99M |
Q2 2017 | share | Decrease | -8.61% | -121.72K shares | 1.36M | $5.76 | 1.29M |
Q1 2017 | share | Increase | +357.05% | 1.10M shares | 5.54M | $4.3 | 1.41M |
Q4 2016 | share | Increase | 0.00% | 309.26K shares | 535K | $1.73 | 309.26K |